Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
5′ UTR
Anti-HAV
HAV
Huh7
IRES
PLC/PRF/5
drug screening
subgenomic replicon
vaccine
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
12 05 2020
12 05 2020
Historique:
received:
04
04
2020
revised:
09
05
2020
accepted:
10
05
2020
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
18
2
2021
Statut:
epublish
Résumé
Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis, and this infection occasionally causes acute liver failure. HAV infection is associated with HAV-contaminated food and water as well as sexual transmission among men who have sex with men. Although an HAV vaccine has been developed, outbreaks of hepatitis A and life-threatening severe HAV infections are still observed worldwide. Therefore, an improved HAV vaccine and anti-HAV drugs for severe hepatitis A should be developed. Here, we reviewed cell culture systems for HAV infection, and other issues. This review may help with improving the HAV vaccine and developing anti-HAV drugs.
Identifiants
pubmed: 32408660
pii: v12050533
doi: 10.3390/v12050533
pmc: PMC7291253
pii:
doi:
Substances chimiques
Antiviral Agents
0
Viral Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Biochem Biophys Res Commun. 2004 May 28;318(2):341-5
pubmed: 15120607
J Virol. 2008 Oct;82(20):10118-28
pubmed: 18684812
Antimicrob Agents Chemother. 1990 Jun;34(6):1112-7
pubmed: 2168143
J Med Virol. 1987 May;22(1):57-66
pubmed: 3035080
Med Res Rev. 2014 Sep;34(5):895-917
pubmed: 23722879
Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12
pubmed: 25704089
Virus Res. 1993 May;28(2):187-94
pubmed: 8391192
Vaccine. 1992;10 Suppl 1:S36-9
pubmed: 1335656
J Clin Microbiol. 1986 Mar;23(3):434-40
pubmed: 3007565
Int J Med Sci. 2018 Jul 30;15(11):1153-1159
pubmed: 30123052
Virol J. 2010 Sep 03;7:212
pubmed: 20815893
mBio. 2016 Dec 6;7(6):
pubmed: 27923925
J Virol. 2002 Feb;76(3):1171-80
pubmed: 11773393
Hepatol Res. 2010 Apr 1;40(4):415-23
pubmed: 20561355
Nat Immunol. 2001 Dec;2(12):1109-16
pubmed: 11725301
J Gen Virol. 1988 Aug;69 ( Pt 8):2129-34
pubmed: 2841419
J Virol. 1987 Oct;61(10):3035-9
pubmed: 3041024
Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):
pubmed: 29530949
J Med Virol. 1986 May;19(1):23-31
pubmed: 3009703
Res Virol. 1991 Jul-Aug;142(4):261-70
pubmed: 1665574
Nat Immunol. 2005 May;6(5):447-54
pubmed: 15793575
Acta Virol. 1993 Aug;37(4):209-22
pubmed: 7905235
J Virol. 1991 Apr;65(4):2056-65
pubmed: 1705995
PLoS Pathog. 2011 Sep;7(9):e1002169
pubmed: 21931545
J Virol. 2006 May;80(9):4633-9
pubmed: 16611923
J Virol. 2014 Sep 1;88(17):10252-8
pubmed: 24920812
Hepatol Res. 2012 Mar;42(3):248-53
pubmed: 22151794
Virology. 1995 Oct 1;212(2):686-97
pubmed: 7571438
J Virol. 1985 Nov;56(2):579-88
pubmed: 2997478
Proc Soc Exp Biol Med. 1979 Feb;160(2):213-21
pubmed: 217023
J Virol. 1994 Feb;68(2):1066-74
pubmed: 8289336
J Virol. 1992 Feb;66(2):650-4
pubmed: 1309907
Antiviral Res. 1986 Mar;6(2):103-12
pubmed: 3010855
J Virol. 1996 Nov;70(11):7948-57
pubmed: 8892918
J Clin Transl Hepatol. 2015 Sep 28;3(3):205-10
pubmed: 26623267
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2497-501
pubmed: 3031686
Indian J Gastroenterol. 2015 Nov;34(6):448-52
pubmed: 26589230
Microbiol Immunol. 2020 May;64(5):392-395
pubmed: 32052883
J Virol. 2006 Feb;80(3):1352-60
pubmed: 16415012
Nature. 2013 Apr 18;496(7445):367-71
pubmed: 23542590
Hepatol Int. 2019 Mar;13(2):103-109
pubmed: 30539517
J Virol. 1994 Aug;68(8):5253-63
pubmed: 8035522
J Infect Chemother. 2020 Feb;26(2):282-285
pubmed: 31543437
J Gen Virol. 2002 Sep;83(Pt 9):2183-2192
pubmed: 12185272
Lancet. 1989 May 13;1(8646):1039-41
pubmed: 2565998
Jpn J Infect Dis. 2019 Jan 23;72(1):44-48
pubmed: 30270252
Clin Infect Dis. 2018 Oct 30;67(10):1477-1492
pubmed: 30215672
Infection. 1979;7(6):303-5
pubmed: 232698
mBio. 2017 Sep 5;8(5):
pubmed: 28874468
Biochem Biophys Res Commun. 2015 Oct 23;466(3):567-71
pubmed: 26388050
J Virol. 1991 Nov;65(11):5828-38
pubmed: 1656072
J Virol Methods. 1987 Nov;18(2-3):193-203
pubmed: 2828401
Virus Res. 2002 Oct;89(1):75-88
pubmed: 12367752
PLoS One. 2014 Jul 07;9(7):e101993
pubmed: 24999657
Virology. 1994 Oct;204(1):60-8
pubmed: 8091685
FEBS J. 2019 Feb;286(4):765-787
pubmed: 30461192
Elife. 2019 Feb 25;8:
pubmed: 30801249
Viral Immunol. 2012 Oct;25(5):379-86
pubmed: 23035851
Eur J Med Chem. 2019 Apr 15;168:447-460
pubmed: 30844608
Infect Immun. 1981 Apr;32(1):388-93
pubmed: 6260685
J Virol. 2006 Jun;80(11):5599-610
pubmed: 16699041
MMWR Morb Mortal Wkly Rep. 2019 May 10;68(18):413-415
pubmed: 31071072
Biochem Biophys Res Commun. 2005 May 20;330(4):1217-23
pubmed: 15823573
Hepatol Res. 2012 Aug;42(8):828-34
pubmed: 22776552
Nat Med. 2005 Jul;11(7):791-6
pubmed: 15951748
J Virol. 2018 Apr 13;92(9):
pubmed: 29437974
Antimicrob Agents Chemother. 2005 Sep;49(9):3833-41
pubmed: 16127060
J Med Virol. 1981;7(3):233-9
pubmed: 6270280
EMBO J. 1996 Aug 15;15(16):4282-96
pubmed: 8861957
Viruses. 2016 Sep 20;8(9):
pubmed: 27657111
Antiviral Res. 1995 Sep;28(1):69-80
pubmed: 8585761
J Virol. 1994 Sep;68(9):6064-8
pubmed: 8057483
J Clin Microbiol. 1983 May;17(5):834-9
pubmed: 6306048
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
pubmed: 15939869
Jpn J Infect Dis. 2019 Jan 23;72(1):53-55
pubmed: 30175732
J Virol. 2005 Mar;79(5):2950-5
pubmed: 15709014
J Med Virol. 1990 Jun;31(2):155-60
pubmed: 2167349
J Virol. 2010 Aug;84(16):8342-7
pubmed: 20534860
Med Microbiol Immunol. 1981;170(2):83-9
pubmed: 6275251
J Gen Virol. 1991 Jul;72 ( Pt 7):1677-83
pubmed: 1649901
Biochem Biophys Res Commun. 2005 Jun 3;331(2):621-9
pubmed: 15850805
J Med Virol. 1981;7(4):273-86
pubmed: 6278066
J Virol. 1994 Jan;68(1):548-54
pubmed: 8254770
Sci Rep. 2016 Nov 03;6:35962
pubmed: 27808108
J Virol. 2019 May 15;93(11):
pubmed: 31092684
BMC Cell Biol. 2015 Feb 27;16:4
pubmed: 25886889